$BLLN

Johnson Nancy JoAnn sold $1.8M of BLLN

Johnson Nancy JoAnn (See Remarks) sold 14,199 shares of BillionToOne, Inc. (BLLN) at an average of $128.29 ($126.98–$129.78, $1.82M total) across 4 trades on 2026-07-16 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Johnson Nancy JoAnn
Published Jul 20, 2026, 11:38 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 20, 2026, 11:43 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$BLLN
Neutral
high confidence
Mentioned
$BLLN
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BLLNNeutralLow
01

Why it matters

The newest fact is the disclosed sale size, price range, and that it was executed under a pre-arranged 10b5-1 plan, which typically reduces interpretive weight.

02

Market read

Traders may treat this as routine insider activity with limited fundamental implications, but it can be used to monitor insider selling trends.

03

What to watch

The net holdings after the sale are 6,900 shares, but the article provides no context on prior sale cadence or total insider ownership changes beyond this transaction.

Relevance 5/10Novelty 3/10Timing: Filed on 2026-07-20, covering sales executed on 2026-07-16.

Background

The article is an SEC Form 4 insider transaction disclosure for BillionToOne, Inc. (BLLN).

Company-level read

Ticker impact

$BLLNNeutralHigh confidence
Context

Form 4 shows officer Johnson Nancy JoAnn sold 14,199 shares of BillionToOne at about $128.29 weighted average under a 10b5-1 plan.

Expected impact

Likely minimal immediate price impact; any effect is more about sentiment than new company information.

Evidence & confidence

The filing is a Form 4 insider transaction with a stated pre-arranged 10b5-1 plan, and it does not disclose new operating, regulatory, or financial results.

Market effects

No sector read-through; this is company-specific insider selling with no new guidance or regulatory development.

None indicated.

None indicated.

Counterpoint

Even planned 10b5-1 sales can coincide with internal views on valuation or liquidity needs, so traders may still watch for follow-on selling patterns.

Key entities

  • BillionToOne, Inc.

    Subject of the Form 4 insider transaction disclosure (BLLN).

  • Johnson Nancy JoAnn

    Officer who sold 14,199 shares across four trades on 2026-07-16.

Related articles

$BLLNMedAI 8/10

BillionToOne Stock (BLLN) Falls After Hours: Here's What's Driving the Move - BillionToOne (NASDAQ:BLLN)

BillionToOne (NASDAQ:BLLN) shares fell 28.12% in after-hours after reporting Q2 results. For the quarter ended June 30, 2026, revenue rose to $109.4M from $66.6M, net income was $8.1M ($0.15/share), and gross margin improved to 70%. The company kept 2026 revenue guidance of $450M to $465M and plans Unity Fetal Risk Screen (Aug. 17) and Northstar Origin (Sept. 1) launches.

$BLLNMedAI 8/10

Billiontoone (BLLN) – Research Analysts’ Recent Ratings Updates

BillionToOne (NASDAQ: BLLN) saw multiple analyst rating and target changes. Weiss Ratings upgraded BLLN to “sell (d+)” (from “sell (d)”) on 5/15 and reaffirmed “sell (d)” on 5/1. Guggenheim raised its target to $120 (from $100) and kept a “buy” on 5/13. JPMorgan lifted its target to $125 and maintained “overweight” on 5/7. BTIG cut its target to $130 (from $140) while keeping “buy” on 5/7.